Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2412 (LINC02412) is an autonomously transcribed, long non-coding RNA gene (>200 nucleotides), whose transcript does not overlap with protein-coding genes and is classified as a lincRNA[3][5][6]. LincRNAs play a role in fine-tuning the expression of neighboring genes, often with cell- and tissue-specific functions; they may act through mechanisms such as chromatin remodeling, transcriptional regulation, RNA stabilization, and cell-cycle modulation[5][7]. The functions of individual lincRNAs, including LINC02412, are rapidly being mapped, but for most—including LINC02412—specific molecular and pathophysiological roles remain under study. LINC02412 has been associated in high-throughput screens with gene regulation and may have relevance to cancer biology, but its precise mechanisms and disease associations require further research[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2412 (LINC02412).